Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes

被引：1
|
作者：
Watchorn, David [1 ]
O'Shea, Donal [2 ]
Butler, Marcus W. [1 ]
机构：
[1] Univ Coll Dublin, Sch Med, Dublin, Ireland
[2] St Vincents Univ Hosp, Dublin, Ireland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 07期
关键词：
GLP-1;
D O I：
10.1164/rccm.202011-4162LE
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
下载
收藏
页码：923 / 924
页数：2
相关论文
共 50 条
  • [1] Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists
    Foer, Dinah
    Beeler, Patrick E.
    Cui, Jing
    Karlson, Elizabeth W.
    Bates, David W.
    Cahill, Katherine N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (07) : 831 - 840
  • [2] Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabet Reply
    Foer, Dinah
    Beeler, Patrick E.
    Cui, Jing
    Karlson, Elizabeth W.
    Bates, David W.
    Cahill, Katherine N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (07) : 924 - 925
  • [3] COPD Exacerbations in Patients With Type 2 Diabetes on Glucagon-like Peptide-1 Receptor Agonists
    Foer, D.
    Strasser, Z. H.
    Cui, J.
    Cahill, K. N.
    Murphy, S. N.
    Karlson, E. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [4] Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence
    Alan G. Kaplan
    James W. Kim
    Pulmonary Therapy, 2022, 8 : 343 - 358
  • [5] Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
    Hansen, K. B.
    Knop, F. K.
    Holst, J. J.
    Vilsboll, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (08) : 1154 - 1160
  • [6] Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence
    Kaplan, Alan G.
    Kim, James W.
    PULMONARY THERAPY, 2022, 8 (04) : 343 - 358
  • [7] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Ju-Ming Lu
    Advances in Therapy, 2019, 36 : 798 - 805
  • [8] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Lu, Ju-Ming
    ADVANCES IN THERAPY, 2019, 36 (04) : 798 - 805
  • [9] Effectiveness of glucagon-like peptide-1 agonists in type 2 diabetes
    Pavlicek, Vojtech
    DIABETOLOGIE, 2023, 19 (03): : 359 - 360
  • [10] Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
    Niazi, Siar
    Gnesin, Filip
    Thein, Anna-Sophie
    Andreasen, Jens R.
    Horwitz, Anna
    Mouhammad, Zaynab A.
    Jawad, Baker N.
    Niazi, Zia
    Pourhadi, Nelsan
    Zareini, Bochra
    Meaidi, Amani
    Torp-Pedersen, Christian
    Kolko, Miriam
    OPHTHALMOLOGY, 2024, 131 (09) : 1056 - 1063
12345